ArticleRSC advances2024

Immunomodulatory zymosan/ι-carrageenan/ agarose hydrogel for targeting M2 to M1 macrophages (antitumoral).

Geetha Venkatachalam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.